Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.

Spahn TW, Eugster HP, Fontana A, Domschke W, Kucharzik T.

Infect Immun. 2005 Nov;73(11):7077-88. Review. No abstract available.

2.
3.

Development and maturation of Langerhans cells, spleen and bone marrow dendritic cells in TNF-alpha/lymphotoxin-alpha double-deficient mice.

Koch F, Ivarsson L, Janke K, Stoitzner P, Ryffel B, Eugster HP, Romani N.

Immunol Lett. 2005 Jan 15;96(1):109-20.

PMID:
15585314
4.

Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes.

Prinz M, Huber G, Macpherson AJ, Heppner FL, Glatzel M, Eugster HP, Wagner N, Aguzzi A.

Am J Pathol. 2003 Apr;162(4):1103-11.

5.

Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3.

Eriksson U, Kurrer MO, Schmitz N, Marsch SC, Fontana A, Eugster HP, Kopf M.

Circulation. 2003 Jan 21;107(2):320-5.

PMID:
12538435
6.

Bioavailability of recombinant tumor necrosis factor determines its lethality in mice.

Ameloot P, Takahashi N, Everaerdt B, Hostens J, Eugster HP, Fiers W, Brouckaert P.

Eur J Immunol. 2002 Oct;32(10):2759-65.

7.

Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha.

Olleros ML, Guler R, Corazza N, Vesin D, Eugster HP, Marchal G, Chavarot P, Mueller C, Garcia I.

J Immunol. 2002 Apr 1;168(7):3394-401.

8.

Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction.

Magez S, Stijlemans B, Caljon G, Eugster HP, De Baetselier P.

Infect Immun. 2002 Mar;70(3):1342-51.

9.

Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway.

Eugster HP, Frei K, Winkler F, Koedel U, Pfister W, Lassmann H, Fontana A.

Eur J Immunol. 2001 Aug;31(8):2302-12.

10.

Regulation of chemokines and chemokine receptors after experimental closed head injury.

Otto VI, Stahel PF, Rancan M, Kariya K, Shohami E, Yatsiv I, Eugster HP, Kossmann T, Trentz O, Morganti-Kossmann MC.

Neuroreport. 2001 Jul 3;12(9):2059-64.

PMID:
11435946
11.

Differential effects of TNF and LTalpha in the host defense against M. bovis BCG.

Bopst M, Garcia I, Guler R, Olleros ML, Rülicke T, Müller M, Wyss S, Frei K, Le Hir M, Eugster HP.

Eur J Immunol. 2001 Jun;31(6):1935-43.

PMID:
11433391
12.

Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches.

Spahn TW, Fontana A, Faria AM, Slavin AJ, Eugster HP, Zhang X, Koni PA, Ruddle NH, Flavell RA, Rennert PD, Weiner HL.

Eur J Immunol. 2001 Apr;31(4):1278-87.

13.

Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction.

Eriksson U, Kurrer MO, Bingisser R, Eugster HP, Saremaslani P, Follath F, Marsch S, Widmer U.

Circulation. 2001 Jan 2;103(1):18-21.

PMID:
11136679
14.

TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease.

Probert L, Eugster HP, Akassoglou K, Bauer J, Frei K, Lassmann H, Fontana A.

Brain. 2000 Oct;123 ( Pt 10):2005-19. Review.

PMID:
11004118
15.

Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines.

Stahel PF, Shohami E, Younis FM, Kariya K, Otto VI, Lenzlinger PM, Grosjean MB, Eugster HP, Trentz O, Kossmann T, Morganti-Kossmann MC.

J Cereb Blood Flow Metab. 2000 Feb;20(2):369-80.

PMID:
10698075
16.

Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo.

Mueller C, Corazza N, Trachsel-Løseth S, Eugster HP, Bühler-Jungo M, Brunner T, Imboden MA.

J Biol Chem. 1999 Dec 31;274(53):38112-8.

18.

Reduced antilisterial activity of TNF-deficient bone marrow-derived macrophages is due to impaired superoxide production.

Müller M, Althaus R, Fröhlich D, Frei K, Eugster HP.

Eur J Immunol. 1999 Oct;29(10):3089-97.

20.

Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1.

Eugster HP, Frei K, Bachmann R, Bluethmann H, Lassmann H, Fontana A.

Eur J Immunol. 1999 Feb;29(2):626-32.

21.
22.

TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus.

Hultgren O, Eugster HP, Sedgwick JD, Körner H, Tarkowski A.

J Immunol. 1998 Dec 1;161(11):5937-42.

23.

Correction of the TNF-LT alpha-deficient phenotype by bone marrow transplantation.

Ryffel B, Le Hir M, Müller M, Eugster HP.

Dev Immunol. 1998;6(3-4):253-60.

24.

IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.

Eugster HP, Frei K, Kopf M, Lassmann H, Fontana A.

Eur J Immunol. 1998 Jul;28(7):2178-87.

25.

IL-4 and IL-13 downregulate rolling adhesion of leukocytes to IL-1 or TNF-alpha-activated endothelial cells by limiting the interval of E-selectin expression.

Etter H, Althaus R, Eugster HP, Santamaria-Babi LF, Weber L, Moser R.

Cytokine. 1998 Jun;10(6):395-403.

PMID:
9632524
26.

Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis.

Sahrbacher UC, Lechner F, Eugster HP, Frei K, Lassmann H, Fontana A.

Eur J Immunol. 1998 Apr;28(4):1332-8.

27.

Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice.

Boess F, Bopst M, Althaus R, Polsky S, Cohen SD, Eugster HP, Boelsterli UA.

Hepatology. 1998 Apr;27(4):1021-9.

PMID:
9537442
28.

Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice.

Malipiero U, Frei K, Spanaus KS, Agresti C, Lassmann H, Hahne M, Tschopp J, Eugster HP, Fontana A.

Eur J Immunol. 1997 Dec;27(12):3151-60.

PMID:
9464800
29.

Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis.

Stahel PF, Frei K, Fontana A, Eugster HP, Ault BH, Barnum SR.

Am J Pathol. 1997 Oct;151(4):897-904.

30.

TNF-alpha-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis.

Stahel PF, Frei K, Eugster HP, Fontana A, Hummel KM, Wetsel RA, Ames RS, Barnum SR.

J Immunol. 1997 Jul 15;159(2):861-9.

PMID:
9218605
31.

Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis.

Frei K, Eugster HP, Bopst M, Constantinescu CS, Lavi E, Fontana A.

J Exp Med. 1997 Jun 16;185(12):2177-82.

32.

A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor.

Gauchat JF, Schlagenhauf E, Feng NP, Moser R, Yamage M, Jeannin P, Alouani S, Elson G, Notarangelo LD, Wells T, Eugster HP, Bonnefoy JY.

Eur J Immunol. 1997 Apr;27(4):971-8.

PMID:
9130652
33.

Lack of type 2 T cell-independent B cell responses and defect in isotype switching in TNF-lymphotoxin alpha-deficient mice.

Ryffel B, Di Padova F, Schreier MH, Le Hir M, Eugster HP, Quesniaux VF.

J Immunol. 1997 Mar 1;158(5):2126-33.

PMID:
9036957
34.

Tumor necrosis factor alpha enhances the expression of the interleukin (IL)-4 receptor alpha-chain on endothelial cells increasing IL-4 or IL-13-induced Stat6 activation.

Lugli SM, Feng N, Heim MH, Adam M, Schnyder B, Etter H, Yamage M, Eugster HP, Lutz RA, Zurawski G, Moser R.

J Biol Chem. 1997 Feb 28;272(9):5487-94.

35.

Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis.

Piguet PF, Kaufman S, Barazzone C, Muller M, Ryffel B, Eugster HP.

Int J Exp Pathol. 1997 Feb;78(1):43-8.

36.

Absence of follicular dendritic cells (FDC) in mutant mice with deficient TNF/lymphotoxin (LT) signaling.

Le Hir M, Eugster HP.

Adv Exp Med Biol. 1997;417:487-91. No abstract available.

PMID:
9286408
38.

Cyclosporin A enhances the calcium-dependent induction of AP-1 complex and c-fos mRNA in a T cell lymphoma.

Su Q, Eugster HP, Ryffel B, Dumont FJ.

Biochem Biophys Res Commun. 1996 Dec 4;229(1):249-56.

PMID:
8954114
39.

Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling.

Le Hir M, Bluethmann H, Kosco-Vilbois MH, Müller M, di Padova F, Moore M, Ryffel B, Eugster HP.

J Exp Med. 1996 May 1;183(5):2367-72.

40.

Correction or transfer of immunodeficiency due to TNF-LT alpha deletion by bone marrow transplantation.

Müller M, Eugster HP, Le Hir M, Shakhov A, Di Padova F, Maurer C, Quesniaux VF, Ryffel B.

Mol Med. 1996 Mar;2(2):247-55.

41.

Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice.

Eugster HP, Muller M, Karrer U, Car BD, Schnyder B, Eng VM, Woerly G, Le Hir M, di Padova F, Aguet M, Zinkernagel R, Bluethmann H, Ryffel B.

Int Immunol. 1996 Jan;8(1):23-36.

PMID:
8671586
42.
43.

Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1.

Amar S, Van Dyke TE, Eugster HP, Schultze N, Koebel P, Bluethmann H.

J Inflamm. 1995-1996;47(4):180-9.

PMID:
9144075
44.

Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitis.

Heumann D, Le Roy D, Zanetti G, Eugster HP, Ryffel B, Hahne M, Tschopp J, Glauser MP.

J Inflamm. 1995-1996;47(4):173-9.

PMID:
9144074
45.

Tumor necrosis factor receptor-1 signaling is required for differentiation of follicular dendritic cells, germinal center formation, and full antibody responses.

Le Hir M, Bluethmann H, Kosco-Vilbois MH, Müller M, di Padova F, Moore M, Ryffel B, Eugster HP.

J Inflamm. 1995-1996;47(1-2):76-80.

PMID:
8913932
46.
47.

Cytochrome P4501A1 mediates the metabolism of 2,3,7,8-tetrachlorodibenzofuran in the rat and human.

Tai HL, McReynolds JH, Goldstein JA, Eugster HP, Sengstag C, Alworth WL, Olson JR.

Toxicol Appl Pharmacol. 1993 Nov;123(1):34-42.

PMID:
8236259
48.
49.

Binding of active cyclosporins to cyclophilin A and B, complex formation with calcineurin A.

Ryffel B, Woerly G, Murray M, Eugster HP, Car B.

Biochem Biophys Res Commun. 1993 Aug 16;194(3):1074-83.

PMID:
8394698
50.

Supplemental Content

Loading ...
Support Center